Injection site management Given the elevated injection site reaction rates with cagrilintide, proactive management is especially important: Rotate injection sites systematically using a rotation schedule (abdomen, right thigh, left thigh, right arm, left arm) Allow the solution to reach room temperature before injecting Inject slowly over 5 to 10 seconds rather than quickly Apply ice before injection to reduce pain Do not massage the injection site afterward Use proper technique as outlined in our peptide injection guide Keeping a log of injection sites and reactions helps identify whether certain areas are more problematic than others
Dosing Range (Systemic ): Research protocols typically use very low doses, often in the microgram (mcg) range, or low single-digit milligrams (mg) per day, reflecting its high biological potency as a signaling molecule
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
Take glutathione supplement 3
